|
|
적색스테인
|
|
 |
WIvVFWXHyr |
 |
367 |
|
 |
| I'm sorry, she's http://xxxnx.world xxlxx Technological advances over the past decade have enabled thedevelopment of direct-acting antivirals (DAAs) that specificallytarget the virus. Two new antiviral drugs, Incivek from VertexPharmaceuticals Inc and Victrelis from Merck & Co, have cured more HCV patients in recent years, but bothare protease inhibitors and are still used in combination withinterferon and ribavirin. |
|
 |
Mya |
 |
2019-05-23 09:24:19 |
|
|
|
|
|
|
|
|
|
